Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

Agenda

Wednesday, 17 February 2016 20:40

HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P 2016)

 

HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

Building on the successes of the inaugural HIVR4P 2014 conference in Cape Town, as well as past biennial microbicide and annual vaccine conferences, HIVR4P 2016 responds to a growing consensus that effective HIV prevention will require a combination of approaches. Viewing these together helps participants to identify the synergies between each approach and the challenges of implementing each most effectively—while also offering opportunities for insight and debate on the state of global HIV prevention efforts as a whole. HIVR4P provides a critically important venue for researchers, clinicians, private sector partners, advocates, policy makers, and public health experts in this dynamic and rapidly evolving field to grapple with the issues that will drive forward a comprehensive biomedical prevention research agenda.

HIVR4P can help to usher in a new, collaborative, and highly productive era in HIV prevention research. Please mark your calendar and plan to be with us in Chicago, 17–20 October 2016.

http://hivr4p.org/

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn
Read 1142 times Last modified on Wednesday, 17 February 2016 22:22